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Endothelial-dependent mechanisms of mononuclear
cell influx are not well understood. We showed that
acute stimulation of murine microvascular endothe-
lial cells expressing the tumor necrosis factor recep-
tors TNFR1 and TNFR2with the soluble cytokine TNF
led to CXCR3 chemokine generation. The TNF recep-
tors signaled through interferon regulatory factor-1
(IRF1) to induce interferon-b (IFN-b) and subsequent
autocrine signaling via the type I IFN receptor and the
transcription factor STAT1. Both TNFR2 and TNFR1
were required for IRF1-IFNb signaling and, in human
endothelial cells TNFR2 expression alone induced
IFN-b signaling and monocyte recruitment. In vivo,
TNFR1 was required for acute renal neutrophil and
monocyte influx after systemic TNF treatment,
whereas the TNFR2-IRF1-IFN-b autocrine loop was
essential only for macrophage accumulation. In a
chronic model of proliferative nephritis, IRF1 and
renal-expressed TNFR2 were essential for sustained
macrophage accumulation. Thus, our data identify a
pathway in endothelial cells that selectively recruits
monocytes during a TNF-induced inflammatory
response.
INTRODUCTION
Inflammation is characterized by leukocyte recruitment and is
choreographed largely by cytokines such as tumor necrosis fac-
tor-a (TNF-a), which is widely recognized for its prominent role in
inflammatory and autoimmune diseases (Ernandez and Maya-
das, 2009). Many of the proinflammatory responses of TNF
in vivo can be traced to its effects on the vascular endothelium
and leukocyte infiltration (Bradley, 2008). TNF induces the
expression of endothelial adhesion molecules that support
leukocyte-endothelial interactions and stimulates the local pro-
duction of chemokines that promote leukocyte activation and
transmigration into tissue (Bradley, 2008; Vassalli, 1992).Different chemokines control the movement of distinct subsets
of immune cells into tissues (Luster et al., 2005). In cultured
endothelial cells, acute TNF stimulation induces neutrophil che-
moattractants such as CXCL8 (IL8), CXCL1 (Gro1), and CXCL2
(MIP-2) through the activation of NF-kB and MAPK (Bradley,
2008; Kuldo et al., 2005). In contrast, well-documented mononu-
clear chemokines, CXCL10 (IP-10), CXCL9 (Mig), and CCl5
(RANTES) are not significantly induced by TNF alone in many
endothelial cell culture systems (Hillyer et al., 2003; Piali et al.,
1998), despite the rapid induction of CXCL10 in the microvas-
cular endothelium following systemic TNF stimulation (Ohmori
et al., 1993).
TNF’s responses are relayed by two distinct receptors,
TNFR1, constitutively present on virtually all cell types and
TNFR2, expressed on leukocytes and endothelial cells (Bradley,
2008). TNFR1 has been widely studied and exhibits both proin-
flammatory and immunosuppressive roles (Vielhauer and Maya-
das, 2007). The function of TNFR2 is less clear. In vitro, its role in
endothelial cells is likely underestimated, because it is often un-
detectable under baseline conditions. Moreover, it more avidly
binds the membrane-bound versus the soluble form of the cyto-
kine used routinely in in vitro assays (Grell et al., 1995; MacEwan,
2002). In vivo, TNFR2 is induced on the endothelium (Lucas et al.,
1997; Vielhauer et al., 2005), and its deficiency in mice protects
from the development of experimental proliferative glomerulone-
phritis (GN) (Vielhauer et al., 2005) and experimental cerebral
malaria (Lucas et al., 1997). In both cases, resistance is attrib-
uted to a lack of endothelial TNFR2 and leukocyte infiltration.
In contrast, in GN, TNFR1 deficiency results in early and transient
protection but then leads to enhanced indices of renal injury
associated with excessive renal accumulation of T cells that
may be attributed to a delay in their apoptosis (Vielhauer et al.,
2005). Studies in transgenic mice also support a role for endo-
thelial TNFR2 in leukocyte accumulation. For example, TNFR2
causes perivascular inflammation associated with TNFR2
expression on the vascular endothelium in mice overexpressing
a noncleavable mutant form of TNF in astrocytes (Akassoglou
et al., 2003).
TNF regulates cellular responses primarily by influencing gene
transcription. There is evidence that TNF induction of interferon-
b (IFN-b) shapes the transcriptional and biological response to
TNF (Fujita et al., 1989; Leeuwenberg et al., 1987; Tliba et al.,Immunity 38, 1025–1037, May 23, 2013 ª2013 Elsevier Inc. 1025
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Figure 1. CXCR3 Chemokine Expression in Microvascular Endothelial Cells Is Dependent on Autocrine IFN-b Production
(A) Left panels show flow cytometric analysis of nonpermeabilizedWT, Tnfrsf1a/, and Tnfrsf1b/MHEC stained with TNFR2 antibody. Full histogram is control
IgG staining. Dark grey line histogram is TNFR2 cell-surface expression. Right panels show immunoblot analysis of protein lysates of WTMHEC treated with LPS
or forskolin for the indicated times in hours.
(B–D) WT and Ifnar1/ cells were treated for 4 hr with IFN-b, TNF, or PBS and subjected to quantitative real-time PCR (qPCR) for Mx1 (related to the IFN type I
response) and CXCR3 chemokines (B), adhesion molecules (C), or neutrophil chemokines (D). *p < 0.05 between Ifnar1/ cells and similarly treatedWT cells. Ns,
nonsignificant.
(E) qPCR analysis for mRNA expression in WT MHEC treated with TNF for 4 hr and treated with either a blocking anti-IFN-b antibody or an isotype control IgG.
*p < 0.05 between TNFwith IgG control and TNFwith IFN-b blocking antibody. For (B)–(E), n = 3 to 5 independent experiments. qPCR data are expressed asmean
mRNA fold-change compared to untreated WT. Error bars indicate SEM.
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TNFR2 Induced IFN-b Supports Monocyte Recruitment2003; Yarilina et al., 2008). TNF induction of IFN-b is dependent
on IRF1 in vitro (Tliba et al., 2003; Yarilina et al., 2008) and is a
mediator of lethal shock induced by TNF in vivo (Huys et al.,
2009). Here, we described a pathway of TNFR2-induced IFN-b
production and autocrine signaling in endothelial cells that leads
to the generation of chemokines that promotemonocyte interac-
tion with the endothelium in vitro and renal monocyte accumula-
tion in vivo.
RESULTS
TNF Induces Expression of Type I Interferon-Response
Genes
We found that unlike cultured human endothelial cells, mouse
heart microvascular endothelial cells (MHEC) constitutively ex-
press TNFR2 (encoded by Tnfrsf1b) RNA (data not shown) and1026 Immunity 38, 1025–1037, May 23, 2013 ª2013 Elsevier Inc.protein on the cell surface (Figure 1A). The mediators that in-
crease TNFR2’s expression remain largely undefined. Higher
TNFR2 protein expression was detected after lipopolysaccha-
ride (LPS) stimulation or cAMP elevation (Figure 1A). The latter
is consistent with the presence of CREB-binding sites in
TNFR2’s promoter (Santee and Owen-Schaub, 1996). To
explore the contribution of TNFR2 to TNF mediated responses,
we treated MHEC from wild-type (WT) and Tnfrsf1b/ mice
with TNF for 4 hr and assessed their transcription profile via
genome-wide microarrays. As anticipated, TNF increased a
number of proinflammatory genes. Among these, genes that
are established targets of IFN-b represented a large fraction
(38%; 120/314) (Table 1). CXCL9, CXCL10, and CCL5, which
are well-described IFN-inducible mononuclear cell chemoat-
tractants (Lacotte et al., 2009) were the three most highly
TNF-induced genes, a finding not previously noted in other
Table 1. TNF-Induced Genes in WT and TNFR2-Deficient Mouse Heart Endothelial Cells Identified by Transcriptional Profiling
Rank Gene Symbol Gene Name
Probe Intensity (Mean Logarithm)
Fold-Change
WT
Fold-Change
Tnfrsf1b/
WT Tnfrsf1b/
PBS TNF PBS TNF
#1 Cxcl10 chemokine (C-X-C motif) ligand 10 6.19 11.89 6.33 11.00 297.65 106.10
#2 Cxcl9 chemokine (C-X-C motif) ligand 9 3.46 7.98 3.50 6.64 91.92 23.00
#3 Ccl5 chemokine (C-C motif) ligand 5 5.71 10.15 6.09 8.92 84.84 16.88
#4 Mx1 myxovirus (influenza virus) resistance 1 4.62 8.85 4.41 7.85 69.19 31.45
#5 Ccrl2 chemokine (C-C motif) receptor-like 2 5.32 9.40 5.41 8.28 59.20 17.66
#6 Ubd ubiquitin D 4.27 8.27 4.60 7.36 54.69 15.72
#7 Cxcl11 chemokine (C-X-C motif) ligand 11 4.13 7.79 3.98 6.70 38.85 15.23
#8 Ccl7 chemokine (C-C motif) ligand 7 8.84 12.49 9.29 12.11 38.67 16.83
#9 2510004L01Rik RIKEN cDNA 2510004L01 gene 7.86 11.44 7.72 10.59 35.83 17.57
#10 Slc15a3 solute carrier family 15, member 3 3.53 7.09 3.88 6.38 35.23 12.21
The ten genes most highly upregulated by treatment of WT MHEC with TNF are shown. Mean logarithm of probe intensity of the two independent ex-
periments is given for WT and Tnfrsf1b/MHEC treated with PBS or TNF for 4 hr. Fold-change between PBS and TNF treated groups are shown for
both genotypes. Bolded and italicized are genes known to be IFN-b inducible. Lower upregulation of genes including Cxcl10, Cxcl9, Ccl5, Cxcl11, and
Mx1 is observed in Tnfrsf1b/ MHEC.
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1998). These chemokines were markedly diminished when
TNFR2 was absent (Table 1).
To explore whether IFN-b signaling contributes to the tran-
scriptional response to TNF, we used MHEC lacking the type I
IFN receptor (IFNAR, which is encoded by Ifnar1). First, we
showed that MHEC treated with recombinant IFN-b expressed
Mx1, a well-described IFN type I inducible gene and CXCL9
and CXCL10 in an IFNAR-dependent manner (Figure 1B).
IFN-b did not induce E-selectin or ICAM-1 (Figure 1C). Notably,
recombinant TNF-a induced the expression of adhesion mole-
cules, Mx-1 and chemokines, but only expression of Mx1,
CXCL9, and CXCL10 required IFNAR (Figures 1B and 1C) as
did CCL5 (data not shown). Thus, like the classical IFN respon-
sive gene Mx1, TNF-induced expression of monocyte chemoat-
tractants CXCL9 and CXCL10 requires IFNAR, whereas TNF in-
duction of neutrophil chemokines CXCL1 and CXCL2 did not
require IFNAR (Figure 1D). IFN-b increased VCAM-1, and TNF-
induced VCAM-1 expression was partially IFNAR-dependent
(Figure 1C). A highly selective IFN-b-depleting antibody mark-
edly inhibited TNF-induced Mx1 and CXCL10, whereas E-selec-
tin was unaffected (Figure 1E), suggesting that activation of IFN-
b signaling after TNF stimulation was based on induction and
secretion of IFN-b. The dependence on IFN-b alone is aligned
with our observation that none of the microarray probes specific
for IFN-a reached significant signal levels after TNF treatment
(data not shown). Together, our data indicate that TNFR2 aug-
ments IFN-b gene expression and the induction of IFN-b-respon-
sive mononuclear chemokines.
Synergistic Role for Endothelial TNFR1 and TNFR2 in
IFN-b Production and Autocrine Signaling
A mechanism for our findings is that TNFRs induce IFN-b itself
because this was abolished in the absence of either TNFR2 or
TNFR1 (encoded by Tnfrsf1a), albeit residual expression was
slightly higher in Tnfrsf1b/ MHEC (Figure 2A). Consistent
with this, the induction of Mx1 and monocyte chemokineswas significantly reduced in the absence of either TNFR
(Figure 2B). The observed higher expression of Mx1, CXCL9,
and CXCL10 in the Tnfrsf1b/ versus Tnfrsf1a/ cells may
be secondary to residual IFN-b amounts in the former versus
the latter. TNF-induced E-selectin, ICAM and VCAM (Figure 2C),
neutrophil chemokines CXCL1 and CXCL2, and the neutrophil
and monocyte chemoattractant CCL2 (Figure 2D) did not
require TNFR2 when TNFR1 was present. IFN-b induces genes
through interaction with IFNAR and activation of STAT tran-
scription factors (Theofilopoulos et al., 2005). Protein blot anal-
ysis of TNF stimulated MHEC revealed rapid and sustained
induction of STAT1 phosphorylation in WT cells that depended
on IFNAR, TNFR1, and TNFR2 (Figure 2E). Thus, both TNFR1
and TNFR2 induce the synthesis of IFN-b and subsequent
IFN-b autocrine signaling through IFNAR.
TNF Induces IFN-b Expression through De Novo
Synthesis of IRF1
Next, we explored the TNF-derived signals that induce IFN-b
transcription, which for other stimuli involves members of the
IRF family including IRF1, 3, 5, and 7 (Theofilopoulos
et al., 2005). TNF-induced generation of IFN-b message was
partially dependent on de novo protein synthesis and was abol-
ished by the NF-kB inhibitor Bay11-782 (Figure 3A). A 4 hr TNF
stimulation of MHEC led to a significant increase in IRF1 and
IRF5 mRNA (Figure 3B) but not IRF3 or IRF7. A deficiency in
TNFR1 led to a reduction in IRF1 and 5 mRNA whereas
TNFR2 deficiency primarily affected IRF1 (Figure 3B), the induc-
tion of which preceded that of IFN-b (Figure 3C). TNF stimulated
IRF1 production was dependent on TNFR1 and partially on
TNFR2 as assessed on protein blots (Figure 3D). IRF1 production
was preserved in Ifnar1/ cells (Figure 3D), indicating that IRF1
is upstream of IFNAR. Studies in Irf1/MHEC showed that IRF1
was essential for TNFmediated IFN-b, Mx1, CXCL9 and CXCL10
mRNA (Figure 3E), and STAT1 phosphorylation (Figure 3F). Thus,
IFN-b transcription and IFN-dependent gene expression in
MHEC upstream of IFNAR depends on IRF1.Immunity 38, 1025–1037, May 23, 2013 ª2013 Elsevier Inc. 1027
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Figure 2. TNF Induces IFN-b Production, STAT1 Phosphorylation, and Mononuclear Chemoattractants in Mouse Microvascular Cells that
Depend on TNFR1 and TNFR2
WT, Tnfrsf1a/, and Tnfrsf1b/MHEC treated with PBS control () or TNF (+) for 4 hr were subjected to qPCR for mRNA expression of (A) IFN-b, (B) Mx1 and
mononuclear chemokines, (C) adhesion molecules, and (D) neutrophil chemokines and Ccl2. n = 3 to 5 independent experiments. *p < 0.05 between WT and
Tnfrsf1a/ or Tnfrsf1b/ MHEC after TNF treatment. Ns, non-significant. Data are expressed as mean mRNA fold-change. Error bars indicate SEM.
(E) Immunoblot of phospho-STAT1 after TNF treatment of WT, Tnfrsf1a/, Tnfrsf1b/, and Ifnar1/ cells for the indicated times in hours. Tubulin (tub) is the
protein loading control. One of four representative experiments is shown.
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TNFR2 Induced IFN-b Supports Monocyte RecruitmentTNFR2 Activation in Human Endothelial Cells Induces
IRF1, IFN-b, and CXCR3 and Supports Monocyte
Recruitment
Humanumbilical vein endothelial cells (HUVEC) hadbarelydetect-
able surface levels of TNFR2 (Figure 4A). This low expression of
TNFR2 and its known suboptimal engagement with soluble TNF
routinely used in vitro likely underestimates TNFR2’s contribution
to TNF-dependent functions in these cells. Thus we overex-
pressed TNFR2 in HUVEC (Figure 4A) because this leads to spon-
taneous receptor clustering and ligand-independent signaling
(Gaeta et al., 2000). TNF treatment of GFP-transduced HUVEC1028 Immunity 38, 1025–1037, May 23, 2013 ª2013 Elsevier Inc.led to enhanced expression of adhesion molecules E-selectin,
ICAM-1, and VCAM-1, whereas TNFR2 transduced HUVEC ex-
hibited an increase only in ICAM-1 and VCAM-1 (Figure 4B).
TNFR2 overexpression significantly induced transcripts of
CXCL9 and CXCL10, whereas soluble TNF treatment of HUVEC
led to a smaller increase in these two chemokines (Figure 4C).
Secreted protein amounts of CXCL10 and another mononuclear
chemokine, CCL5, were only measurable in TNFR2 overexpress-
ing cells (Figure 4D), whereas both TNF-stimulated and TNFR2-
transduced cells secretedCXCL1 (Figure 4D). TNFR2 overexpres-
sion increased IFN-b, Mx-1, IRF1 and IRF7 albeit IRF7 induction
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Figure 3. TNF Induces IRF1 Mediated IFN-b Autocrine Signaling
(A) WT MHEC were pretreated with cycloheximide (CHX) or an NF-kB inhibitor (Bay11-7082) followed by incubation with TNF (+) or PBS () for 4 hr and IFN-b
mRNA levels were evaluated by qPCR.
(B) qPCR analysis of IRF1, IRF3, IRF5, and IRF7 following a 4 hr TNF treatment in WT cells (left panel). qPCR data are normalized to GAPDH and expressed as
2DCt to allow relative comparison between the different IRF isoforms. qPCR analysis of IRF1 and IRF5mRNA expression inWT, Tnfrsf1a/, and Tnfrsf1b/ cells
(right panel).
(C) Time course of IFN-b and IRF1 mRNA expression measured by qPCR in WT cells following TNF treatment.
(D) Indicated MHEC were treated with TNF for the times shown and samples were subjected to immunoblot analysis for IRF1 (arrowhead). Actin is a protein
loading control. One representative of three experiments is shown.
(E) qPCR analysis of IFN-b and target gene expression 4 hr after TNF treatment of WT and Irf1/ MHEC.
(F) WT and Irf1/ cells were treated with TNF for the indicated times in hours and STAT1 phosphorylation (arrowhead) was evaluated by immunoblot. One
representative of three experiments is shown. n = 3 independent experiments for each graph shown except (B), which is n = 2. *p < 0.05 between WT and
the indicated knockout MHEC after TNF treatment.
qPCR data are expressed as mean mRNA fold-change except where otherwise specified. Error bars indicate SEM.
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Figure 4. TNFR2 Overexpression in Human Umbilical Vein Endothelial Cells Induces IRF1, IFN-b, and CXCR3 Chemokines and Supports
Monocyte Recruitment
HUVEC were transduced with lentivirus expressing control GFP alone (GFP) or Flag-tagged TNFR2 (TNFR2).
(A) Left panel shows nonpermeabilized cells that were stained with anti-human TNFR2 antibody and subjected to flow cytometric analysis. Grey is control isotype
IgG and black and green histograms represent GFP and TNFR2 transduced HUVEC, respectively. Right panel shows TNFR2-Flag HUVEC that were per-
meabilized, stained with an anti-Flag antibody, and analyzed by confocal microscopy. White arrow indicates TNFR2-Flag staining at the cell surface.
(B) Cells transduced with either GFP or TNFR-Flag were treated with PBS or TNF (+TNF) and subjected to flow cytometry analysis as in (A) by using anti-E-
selectin, ICAM-1, or VCAM-1 antibodies. One representative of three is shown.
(C–E) qPCR analysis of Cxcl9 and Cxcl10mRNA (C), quantification of secreted chemokines by ELISA (D), and qPCR analysis of IFN-b, Mx1, IRF1, and IRF7mRNA
levels in HUVEC transduced with either GFP or TNFR2-Flag and incubated without () or with (+) TNF. ND, not detectable. n = 3 independent experiments. See
also Figure S1.
(F) Neutrophils or mononuclear cells (10%–13% were monocytes) were perfused across GFP- or TNFR2-transduced HUVEC. Cells that arrested and trans-
migrated were enumerated. Data is mean ± SD from three independent experiments. Left and middle panels show representative phase-contrast images.
Mononuclear cells adhered (arrow) and transmigrated (arrowhead). Right panel shows immunofluorescence staining for cells positive for CD14+ (monocyte
marker, arrowhead) interacting with the endothelium. qPCRdata are expressed asmeanmRNA fold-change. Error bars indicate SEM. *p < 0.05 compared toGFP
() transduced samples.
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shown) suggesting that IRF7 is downstream of IFN-b-IFNAR
signaling. It is notable that TNF treatment of HUVEC led to the in-
duction of IRF1 despite the lack of IFN-b expression (Figure 4E).
Thus IRF1 induction is not sufficient for upregulation of IFN-b
mRNA as shown in other cell lines (Fujita et al., 1989) and implies
that TNFR2 in HUVEC engages additional pathways necessary
for IFN-b production. TNFR2 overexpression in human dermal
microvascular endothelial cells (HDMEC) also induced Mx-1 and
Cxcl10 (see Figure S1 available online), suggesting that this
pathwayoperates in largeveinandmicrovascularhumanendothe-
lial cells. The induction of CXCL10mRNA in the absence of signif-
icant IFN-b or Mx1 in HUVEC and HDMEC stimulated with TNF
suggests that canonical TNFR1-dependent signals may also
contribute to this process.
Next, we assessed the functional consequences of TNFR2
expression in HUVEC for leukocyte recruitment under flow con-
ditions. For this, purified human neutrophils or the mononuclear
fraction from human blood were drawn across GFP- or TNFR2-
transduced HUVEC. TNFR2, but not GFP overexpression, led to
significant adhesion and transmigration of mononuclear cells.
Only CD14+ monocytes present in the mononuclear fraction
adhered and transmigrated across TNFR2-HUVEC (Figure 4F).
Cxcl10 and its receptor CXCR3 promote monocyte recruitment
in mice in vivo (Zhou et al., 2010). Although expression of
CXCR3 on circulating human monocytes is debatable (Katschke
et al., 2001; Taub et al., 1993), endothelial TNFR2 also induces
CCL5 (Figure 4D; Table 1), a well-known monocyte chemoat-
tractant. T cell interactions were not detected, which is in agree-
ment with reports that T cells are unable to bind and transmigrate
in the absence of apically perfused CXCL12 (SDFa) (Cinamon
et al., 2001). TNFR2 induced VCAM-1 (Figure 4B) a known ligand
for a4b1 that supports monocyte adhesion and transmigration
(Luscinskas et al., 1996). A blocking a4 antibody abrogated
monocyte accumulation (data not shown), suggesting that the
TNFR2-induced monocyte interactions with HUVEC are depen-
dent on VCAM-1. TNF-stimulated HUVEC also support mono-
cyte accumulation (data not shown) as reported by others (Lus-
cinskas et al., 1996) and have detectable transcripts for
mononuclear chemokines despite the absence of measurable
IFN-b (Figures 4C and 4E). This infers that TNFR1 can induce
mononuclear chemokines through a canonical, IFN-b-indepen-
dent pathway. In contrast to monocytes, human neutrophils
failed to specifically interact with TNFR2-HUVEC (Figure 4F)
that may reflect the absence of E-selectin on these cells (Fig-
ure 4B) but did accumulate on TNF-treated GFP-HUVEC (data
not shown).
Evidence of a TNFR2-IFN-bAutocrine Loop in theKidney
following Acute TNF Stimulation
The physiological significance of the TNF-induced IFN-b
signaling pathway was evaluated in vivo 2 hrs after an intrave-
nous injection of soluble TNF, which did not result in changes
in heart rate, blood pressure, or peripheral blood counts albeit
neutrophil counts were higher (Table S1). STAT1 was strongly
activated in the kidney of TNF-treated WT mice and was mark-
edly diminished in similarly treated Ifnar1/ mice (Figure 5A). It
was also decreased in both Tnfrsf1a/ and Tnfrsf1b/ animals
to a similar extent implying that in vivo, the contribution of TNFR1and TNFR2 to IFN-b signaling are equivalent. Moreover, a reduc-
tion in phospho-STAT was observed in TNF-treated Irf1/ ani-
mals (Figure 5A), indicating that in vivo, as in vitro, TNF-induced
IFN-signaling requires IRF1. TNF strongly induced IRF1 genera-
tion in kidneys of WT animals, whereas it was absent in
Tnfrsf1a/ mice, partially reduced in Tnfrsf1b/ animals, and
preserved in Ifnar1/ animals (Figure 5B). This demonstrates
that IRF1 is downstream of the TNFRs and upstream of IFN-b
signaling. IFN-b signaling was evident in glomerular endothelial
cells because they were positive for pSTAT by immunohisto-
chemistry (Figure 5C). Finally, renal CXCL10 protein amounts
increased following TNF treatment of WT mice and were depen-
dent on TNFR1, TNFR2, and IFNAR (Figure 5D). Endothelial cells
rather than macrophages are the likely source of this chemokine
because macrophages do not express appreciable amounts of
CXCL10 following a 2 hr TNF stimulation in vivo (Ohmori et al.,
1993) or in vitro (Yarilina et al., 2008).
TNF induced a significant influx of monocyte and neutrophil
influx in WT animals (Figure 5E), whereas T cell accumulation
was minimal (data not shown). Monocyte recruitment was
reduced in Tnfrsf1a/, Tnfrsf1b/, Ifnar/, and Irf1/ mice.
In contrast, neutrophil accumulation, which was absent in
Tnfrsf1a/ animals, was largely preserved in mice lacking
TNFR2, IFNAR, or IRF1 (Figure 5E). Thus, the TNF-induced
IRF1-IFN-b autocrine loop preferentially mediates monocyte
recruitment. To explore the hypothesis that membrane-bound
TNF engages endothelial TNFR2 and promotes monocyte infil-
tration, we administered soluble TNF in TNF-deficient mice
that lack both soluble and membrane TNF. This resulted in
neutrophil recruitment but did not induce mononuclear cell infil-
tration (Figure 5E), inferring that the endogenous membrane-
bound form of TNF is required for mononuclear influx. Next, we
investigated whether neutrophils are a potential source of mem-
brane bound TNF (mTNF). LPS-stimulated human neutrophils
expressed mTNF (Figure 5F) as previously reported (Wright
et al., 2011). LPS- or PBS-treated neutrophils were extensively
washed and incubated with WT, Tnfrsf1a/, or Tnfrsf1b/
MHEC. Two hours later, Mx1 expression was evaluated by using
primers for murine Mx1. This cross-species approach is feasible
because hexameric human TNF, which can resemble mem-
brane-anchored TNF, binds murine TNFR2 with equal efficiency
asmurine TNF (Bossen et al., 2006). PBS-treated neutrophils did
not induceMx1 inWTMHEC. In contrast, LPS pretreated human
neutrophils induced Mx1 in WT, but not in Tnfrsf1a/ or
Tnfrsf1b-/ MHEC (Figure 5F). Thus, membrane-anchored TNF
on neutrophils can potentially induce IFN-b in endothelial cells
through TNFR1 and TNFR2.
Renal-Derived TNFR2 and IRF1 Support Mononuclear
Cell Recruitment following Anti-Glomerular Basement
Membrane Nephritis
Chronic proliferative GN induced by anti-glomerular basement
membrane (GBM) sera in mice results in renal injury that is
dependent on TNF (Timoshanko et al., 2003) and IFNAR (Fair-
hurst et al., 2009). Following induction of anti-GBM nephritis,
Irf1/mice exhibited a reduction in macrophage and neutrophil
accumulation, as well as histopathological indices of disease
(Figure S2). Unexpectedly, proteinuria in Irf1/ mice was
reduced at early (day 7) but not late (day 14 and 21) time pointsImmunity 38, 1025–1037, May 23, 2013 ª2013 Elsevier Inc. 1031
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Figure 5. TNFR2 Induced IFN-b Autocrine Signaling Is Required Selectively for Renal Monocyte Recruitment following Acute Systemic TNF
Treatment
Indicatedmice were given an i.v. injection of TNF (+) or PBS () and kidneys were harvested 2 hr later. STAT1 phosphorylation (A) and IRF1 protein expression (B)
were analyzed by immunoblot of total protein extracts from kidneys. The dashed lines indicate the removal of intervening lanes of the same gel. For (A) and (B), 1 of
3 representative experiments is shown. Bands optical density was quantified and the average fold induction ± SEM normalized to controlWT PBS sample is given
for each treatment.
(legend continued on next page)
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tion may be attributed to a role for IRF1 and associated IFN-b
signaling in directly maintaining the glomerular filtration barrier
(Satchell et al., 2007).
We previously reported that renal-derived TNFR2 promotes
macrophage accumulation at day 21 following induction of
nephritis. In contrast, opposing effects of TNFR1 in early and
late stagesofGNwereobserved, reflectingboth theproinflamma-
tory and suppressive functions of TNFR1 (Vielhauer et al., 2005).
Here, we examined glomerular neutrophil influx, as well as a
time course of macrophage accumulation in WT, Tnfrsf1a/,
and Tnfrsf1b/ mice following induction of anti-GBM nephritis.
Tnfrsf1a/mice had a delay in neutrophil and macrophage infil-
tration,whereasTnfrsf1b/ animals exhibited a sustained reduc-
tion inaccumulationofboth leukocytesubsets throughout thedis-
easecourse (FigureS2).Consistentwith this, onlyTnfrsf1b/and
not Tnfrsf1a/mice had a significant reduction in several param-
eters of renal damage (proteinuria, fibrinoid necrosis and cres-
cents) (Figure S2). Next, we assessed the role specifically of renal
derived TNFR2 in leukocyte infiltration. The experiment was de-
signed to also address whether the observed absence of intersti-
tial macrophages in the Tnfrsf1b/ mice reflects a curtailed
neutrophil influx or a direct role for TNFR2 in macrophage recruit-
ment. That is, we prepared bone marrow chimeras by using WT,
Tnfrsf1a/, and Tnfrsf1b/ mice as recipients of bone marrow
harvested not from WT mice but from mice deficient in the com-
mon g-chain (Fcer1g/) (i.e., lacking murine-activating FcgRs
for immunoglobulin G [IgG]) that express human FcgRs, FcgRIIA,
and FcgRIIIB (hFcgRs-Fcer1g/) on neutrophils. The reason this
approach was chosen is because following anti-GBM nephritis,
glomerular neutrophil influx in hFcgRs-Fcer1g/ mice clearly
precedes macrophage accumulation and is dependent exclu-
sively on neutrophil hFcgR recognitionof IgG-immunecomplexes
(Tsuboi et al., 2008). Thus, we anticipated that our study design
would lead to neutrophil influx in the bonemarrow chimeras inde-
pendent of the TNFR present in the recipients. We found that WT
mice reconstitutedwith Fcer1g/ bonemarrowwere completely
protected fromdeveloping renal injury (FigureS2), thusconfirming
the importance of FcgRs in circulating cells in neutrophil accumu-
lation anddisease induction.WT,Tnfrsf1a/, orTnfrsf1b/mice
with hFcgRs-Fcer1g/ bone marrow exhibited comparable
neutrophil accumulation at day 7.Macrophage influxwasminimal
at this time point. At day 14, a dramatic increase in periglomerular
and interstitial macrophage accumulation was observed in both
chimeric WT and Tnfrsf1a/ mice. In contrast, no increase in
macrophage accumulationwas observed in chimeric Tnfrsf1b/
mice. Proteinuria and histopathological indices of disease were
consistently reduced only in the reconstituted Tnfrsf1b/ mice
(Figures 6A and 6B). Thus, TNFR2 on intrinsic renal cells supports(C) Phospho-STAT1 immunohistochemistry staining of kidneys of indicated mic
endothelial cells is indicated (arrows) and semiquantitative scores of staining (m
(D) Immunoblot analysis of Cxcl10 protein expression in kidney lysates. Quantific
(E) In PBS () or TNF (+TNF) treated mice, renal macrophage, and neutrophil recru
interstitial and periglomerularmacrophages (arrows) (upper panel) and glomerular
mean percentage ± SEM normalized to WT + TNF (set at 100). n = 3–4 mice per g
TNF (WT +) and indicated knockout mice. See also Table S1.
(F) Flow cytometry analysis of membrane-bound TNF (mTNF) in human neutrophil
neutrophils were incubated with MHEC isolated from indicated mice for 2 hr. M
primers. Results are expressed as mean mRNA fold-change. Error bars indicatemonocyte recruitment in a manner that is independent of the pre-
ceding neutrophil influx, and is the primarymediator of renal injury
in GN. Our findings may have correlates in human conditions. We
observed that TNFR2, absent in normal human kidney, was
induced on the glomerular endothelium of patients with anti-
GBM glomerulonephritis (Figure 6C). Additional staining of
intrinsic renal cells is also observed and may reflect expression
of TNFR2 on podocytes.
DISCUSSION
The importance of TNF in inflammatory responses and immune
regulation is unquestionable, but the mechanisms by which this
cytokine triggers specific cellular responses are not well defined.
Moreover, the individual role of TNFR2 is largely debated.
Through a comprehensive approach encompassing transcrip-
tional profiling and biochemistry, our studies revealed that acute
TNF stimulation induced a strong IFN type I response in endothe-
lial cells through an IRF1-IFN-b-IFNAR-STAT1 regulatory path-
way that selectively enhanced the expression of mononuclear
chemokines.Optimal generationof IFN-b leading tomononuclear
chemokine production relied on TNFR2. InMHEC, TNFR2plays a
supportive role in triggering the IFN-b autocrine loop. However,
when overexpressed in endothelial cells, or in vivo, under condi-
tionsofmorephysiological TNFR2activation (e.g., bymembrane-
anchored TNF), TNFR2 plays a primary role in monocyte recruit-
ment. In vivo, renalmacrophageaccumulationwasdependent on
TNFR2 both following acute TNF stimulation and anti-GBM
nephritis. On the other hand, TNFR1, although essential for
monocyte influx following systemic treatment with soluble TNF,
is insufficient to support this function in the context of anti-GBM
nephritis. The receptor requirements for neutrophil accumulation
depend on the primary initiating stimulus. In the case of systemic
soluble TNF TNFR1 predominates while under conditions of
in situ immune complex deposition FcgRs primarily operate.
In MHEC, TNFR1 was needed for stimulation of TNF-respon-
sive genes across all the gene clusters including adhesion
molecules, chemokines, and IFN-b responsive genes. On the
other hand, TNF-induction of IFN-b also required TNFR2, sug-
gesting that TNFR2 acts synergistically with TNFR1 for the
generation of IFN-b and downstream signaling. TNFR2 and
IFN-b signaling were not essential for expression of adhesion
molecules and neutrophil chemokines, thus establishing the
importance of TNF-induced IFN-signaling in the transcription
of a subset of proinflammatory genes. Although the exact mech-
anism of synergy of TNFR2 with TNFR1 in the context of soluble
TNF was not elucidated in our studies, the observation that
TNFR2 ligand independent activation in human endothelial cells
can generate IFN-b and CXCL10 indicates that this receptor hase treated (+) or not with TNF. Phospho-STAT1-positive staining in glomerular
eans ± SEM) are given from three independent experiments.
ation was performed as in (A) and (B).
itment was assessed by immunohistochemistry. Representative pictures show
neutrophils (arrows) (middle panel). Results were quantitated and expressed as
roup except for IRF/mice, which is n = 2. *p < 0.05 between WT treated with
s stimulated with LPS for 30min. Quiescent () or LPS-prestimulated (+) human
x1 mRNA expression was then quantified by qPCR by using specific murine
SEM. n = 3.
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Figure 6. TNFR2 Induced IFN-b Autocrine Signaling Promotes Monocyte Recruitment following anti-GBM Nephritis
(A and B) WT, Tnfrsf1a/, and Tnfrsf1b/ mice reconstituted with hFcgR-Fcegr1/ bone marrow were subjected to anti-GBM nephritis. (A) Proteinuria is
graphed. Each data point represents one mouse, and the solid line is the median of the group. The dashed line indicates the mean of proteinuria in WT mice with
Fcegr1/ bone marrow at day 14. Indicated parameters were assessed following immunohistochemistry for neutrophils and macrophages, and Periodic Acid-
Schiff (PAS) staining (fibrinoid necrosis) (n = 4–5 per time point). The number of neutrophils per 100 glomeruli or in 10 hpf (403) of the interstitium was quantitated.
F4/80-positive area in 5 hpf (203) is given and at day 0 was 396 ± 150. Data are expressed as mean ± SEM; nd = not determined. *p < 0.05 compared to WT. (B)
Representative pictures of F4/80 stained macrophages and Periodic Acid-Schiff (PAS) stained kidney sections of the indicated animals at day 14 (original
magnification 320). Arrow, macrophage influx; black arrow, fibrinoid necrosis; blue arrow, crescents. See also Figure S2.
(C) Confocal microscopic analysis of normal kidney (top panels) and a renal specimen from a patient with anti-GBM glomerulonephritis (bottom panels). Tissue
was stained with antibody to TNFR (red, left) and an endothelial marker CD31 (green, middle). The merged image (right) shows CD31 and TNFR2 colocalization
(arrow) along the peripheral capillary walls. Original magnification was 360.
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TNFR2 Induced IFN-b Supports Monocyte Recruitmentthe capacity to induce, by itself, IFN-b and downstream
signaling. Moreover, TNFR2 overexpression is sufficient to upre-
gulate some adhesion molecules such as VCAM-1. Consistent1034 Immunity 38, 1025–1037, May 23, 2013 ª2013 Elsevier Inc.with these findings, TNFR2 expressing HUVEC supported
monocyte adhesion and transmigration. These results may
explain the observation that TNFR2 transgene expression alone,
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TNFR2 Induced IFN-b Supports Monocyte Recruitmentin the absence of TNF or TNFR1 can lead to multiorgan inflam-
mation (Douni and Kollias, 1998).
Our studies in both endothelial cell culture systems suggests
that one critical role of TNFR2 is the induction of IRF1 gene
expression. Limited signaling pathways have been identified
downstream of TNFR2 and include NF-kB signaling, activation
of the tyrosine kinase Bmx-Etk, and MAPK-JNK (Ernandez and
Mayadas, 2009). Whether these signals are involved in IRF1 gen-
eration remains to be determined. The induction of IFN-b in
response to virus or endotoxin is largely mediated by IRF3 and
IRF7, in collaboration with the NF-kB and AP-1 family of tran-
scription factors (Doyle et al., 2002; Honda et al., 2006; Sakagu-
chi et al., 2003; Sharma et al., 2003). Interestingly, in our work,
IFN-b is transcriptionally upregulated by TNF through a process
requiring de novo synthesis of IRF1. IRF1 has previously been
implicated in the ability of TNF to induce IFN-b in macrophages
(Yarilina et al., 2008), but this did not require new protein
synthesis. Thus, the mechanisms involved in TNF-induced IFN-
signaling vary by cell type and might reflect variances in the rela-
tive contribution of TNFR2 in distinct cell types.
Acute TNF stimulation induced STAT1 phosphorylation,
CXCL10 expression, and mononuclear cell accumulation in the
renal parenchyma, and these events were markedly TNFR2,
IRF1, and IFNAR dependent. The stronger effect of TNFR2 defi-
ciency on induction of CXCL10 and pSTAT1 in vivo than inMHEC
likely reflects the suboptimal activation of TNFR2 by soluble TNF
in tissue culture conditions. In vivo, endothelial TNFR2 could
potentially be engaged by recruited neutrophils expressing
membrane anchored TNF. In addition to availability of mem-
brane bound TNF, our observation that TNFR2 in endothelial
cells is upregulated by LPS or cAMP, suggest that these or other
locally generated mediators could influence the TNF dependent
repertoire of endothelial chemoattractants in vivo. Indeed, the
observed variability in TNF induced CXCR3 chemokine expres-
sion in different microvascular beds (Ohmori et al., 1993) may
be rooted in differing endothelial TNFR2 expression in distinct
anatomic loci. We found that TNFR2 was significantly induced
on the glomerular endothelium of patients with anti-GBM
nephritis. TNFR2 expression was also induced on intrinsic renal
cells. Podocytes have been shown to express TNFR2 in the
context of renal allograft rejection (Al-Lamki et al., 2001; Hoff-
mann et al., 2009) and TNFR2 on these cells promote chemokine
production and monocyte migration in vitro (Bruggeman et al.,
2011). Thus, we speculate that TNFR2 in podocytes may also
engage an IFN-b autocrine loop to generate mononuclear che-
mokines. The unexpected strong induction of mononuclear
chemokines in endothelial cells by TNF-TNFRs in our culture
systems indicates that the endothelium may play a central role
in supplying local chemoattractant cues. In addition to mono-
cytes, the endothelial TNFR2-IFN-b autocrine pathway may
also be relevant to the recruitment of T cells such as the
CXCR3-positive Th1 cells (Taub et al., 1996; Xie et al., 2003;
Luster et al., 2005).
Our data indicate that TNF induced IFN-b production results
in autocrine signaling in endothelial cells that in turn plays a
central role in monocyte recruitment during inflammation and
may potentially contribute to TNF-mediated pathology in a
number of immune-mediated conditions in which a pleiotropic
role for IFN type I is recognized. These include systemic lupuserythematous (SLE) (Bennett et al., 2003), rheumatoid arthritis
(van der Pouw Kraan et al., 2007), multiple sclerosis (Comabella
et al., 2009), sepsis (Decker et al., 2005), and psoriasis (Yao et al.,
2008). We speculate that TNFR2 or intermediate molecules
such as IRF1 could represent promising targets for therapeutics
with potentially safer pharmacological profiles than the current
regimen of TNF blockade (Ernandez and Mayadas, 2009).
EXPERIMENTAL PROCEDURES
Mice
The following mice were used in our study, details of which are in Supple-
mental Experimental Procedures: WT C57Bl6 (WT), mice deficient in TNFR1
(Tnfrsf1a/), TNFR2 (Tnfrsf1b/), TNF-a (Tnf/), IFNAR (Ifnar1/), or IRF1
(Irf1/), and mice transgenically expressing human FcgRIIA and FcgRIIIB
on neutrophils, in the absence of murine activating Fcg receptors (hFcgRs-
Fcer1g/). All genetically engineered mice are on a C57Bl/6 background.
Further details are in the Supplemental Experimental Procedures.
Preparation and Treatment of Endothelial Cell Cultures
Primary MHECs isolation and characterization and HUVEC and HDMEC isola-
tion are described in Supplemental Experimental Procedures. MHECs were
treated with murine TNF (20 ng/ml) or IFN-b (250 U/ml), and collected for
RNA and immunoblot. We added 20 ug/ml neutralizing anti-IFN-b antibody
or IgG isotype control at the same time as TNF. Purified human neutrophils
from fresh blood were stimulated with LPS with gentle shaking. Neutrophils
were collected 30 min later, washed extensively with PBS to remove LPS,
and cocultured with MHEC for 2 hr. HUVEC and HDMEC were stimulated
with 20 ng/ml human TNF.
Preparation of Human Peripheral Blood Neutrophils and
Mononuclear Cells
Human polymorphonuclear neutrophils (PMNs; >95% pure) were isolated
from anticoagulated whole blood drawn from healthy volunteers as described
(Luscinskas et al., 1996). The mononuclear fraction was taken from the buffy
coat and washed with DPBS plus 2% FBS. Monocytes represented 10%–
13% of the total cell population as assessed by FACS analysis with an anti-
CD14 mouse IgG2a monoclonal antibody (Invitrogen).
DNA Constructs and Lentiviral Transduction
Details for construction of TNFR2 lentivirus is in Supplemental Experimental
Procedures. HUVEC were infected with 0.45 mm filtered supernatants of virus
expressing TNFR2 or GFP. After 12 hr, cells were cultured in fresh HUVEC
media and the transduced cells were used for experiments 3.5 days later.
Live-Cell Analysis of Neutrophil and Monocyte Recruitment under
Shear Flow Conditions
We drew 1 3 106 neutrophils or mononuclear cells across TNFR2- or GFP-
transduced HUVEC plated on fibronectin coated coverslips in a flow
chamber at 0.75 or 0.20 dynes/cm2 respectively for 2min and then increased to
1.0 dynes/cm2 and adhesion and transmigration (TEM) were monitored with a
Nikon TE2000 inverted microscope attached to a video camera and recorder
as previously described (Luscinskas et al., 1996). Cells that were stationary or
displaced less than one cell diameter for 30 s were defined as arrested. The
percent TEM was calculated as (total transmigrated leukocytes) O (total
number of adherent and transmigrated cells) 3 100. For antibody blocking,
mononuclear cells were pretreated with functional blocking murine anti-
human a4 monoclonal antibody (20 mg/ml; clone HP2/1) for 30 min. For immu-
nostaining, cells were preincubated with a nonfunctional blocking anti-CD14
(Invitrogen) for 30 min prior to their use in the flow assay.
Flow Cytometric Analysis, Immunofluorescence, and
Immunoblotting
FACS analysis was conducted on endothelial cells detached with trypsin/
EDTA. MHEC TNFR2 was evaluated by using a biotinylated anti-mouse
TNFR2 antibody and streptavidin-PE reagent. HUVECwere fixed and permea-
bilized with 0.1% saponin and stained with anti-flag and Alexa488-anti-mouseImmunity 38, 1025–1037, May 23, 2013 ª2013 Elsevier Inc. 1035
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sue, cryosections were stained with antibody to human TNFR2 (Rabbit poly-
clonal, Abcam) and CD31 (Mouse monoclonal antibody, Dako) and processed
for immunofluorescence by using appropriate secondary antibodies. Cell
lysates prepared from endothelial cells or tissue by using RIPA buffer was sub-
jected to SDS-PAGE and immunoblot analysis following standard protocols
and antibodies detailed in Supplemental Experimental Procedures.
Cytokine Expression Analysis by ELISA
HUVEC were transfected with control GFP or TNFR2 expressing lentivirus and
conditioned media was obtained at 96 hr posttransfection. Expression of
CXCL1, CXCL10, and CCL5 was examined by using the human cytokine
Multi-Analyte ELISArray kit (Super Array) according to the manufacturer’s
protocol.
Transcriptional Profiling and Real-Time Quantitative PCR
Confluent MHEC isolated from WT and Tnfrsf1b/ mice were treated for 4 hr
with PBS vehicle alone or 20 ng/ml recombinant soluble TNF. RNAwas subse-
quently isolated and subjected to gene array analysis as detailed in Supple-
mental Experimental Procedures.
Real-time PCR was performed as described in Supplemental Experimental
Procedures. Except when specified otherwise, results were analyzed by using
the 2DCt method (Livak and Schmittgen, 2001), and differences were ex-
pressed in mean fold-change ± SEM compared to WT PBS control, which is
set at 1.
Acute, Systemic TNF Treatment of Mice and Tissue Histochemistry
Mice were given an intravenous (i.v.) injection of murine TNF (5 mg) in endo-
toxin-free PBS. Two hours later, mice were euthanized and kidneys were
isolated and decapsulated. Tissues samples were either homogenized in
RIPA buffer containing protease and phosphatase inhibitors and processed
for immunoblot analysis or fixed in neutral formalin and paraffin embedded
for immunohistochemistry. Details of immunohistochemistry are in Supple-
mental Experimental Procedures.
Induction and Analysis of anti-GBM Nephritis and Generation of
Bone Marrow Chimeras
Anti-GBM nephritis was induced and analyzed essentially as previously
described (Vielhauer et al., 2005) and detailed in Supplemental Experimental
Procedures. Bone marrow transplantation was performed as follows: Bone
marrow obtained from hFcgRs-Fcer1g/ mice was transferred into lethally
irradiated WT, Tnfrsf1a/, and Tnfrsf1b/mice. One month after reconstitu-
tion, anti-GBM nephritis was induced.
Statistical Analysis
Data are presented as the mean ± SEM. Statistical differences were assessed
using unpaired two-sided t test or ANOVA followed by a Bonferroni’s multiple
comparison test when more than two groups were compared. p values less
than 0.05 were considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.immuni.2013.01.012.
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